ASMI urges CM study
June 7, 2016
The Australian Self Medication
Industry says complementary
medicine research is vital to build
the evidence base about the safety,
efficacy and public health benefits
of the products.
A submission by ASMI to the
government in relation to funding
priorities for the $20 billion Medical
Research Future Fund has been
made public, advocating funding
for CM research to “facilitate
informed policy decisions on the
use of complementary medicines in
preventive health, and in promoting
general health and wellbeing”.
Brenda Davy, ASMI Strategy
Manager for Complementary
Medicines, said CMs were currently
the largest and fastest growing
segment in health care, with 70%
of consumers taking vitamins,
minerals and supplements.
“We know that consumers take
complementary medicines to
prevent some chronic conditions
and contribute to their general
health...we also know that if taken
on a population-wide basis these
medicines can have positive health
outcomes and reduce the financial
burden on government,” she said.
The ASMI document says more
research would help consumers
make informed decisions about
their health, as well as increasing
knowledge about how CMs are
used in settings such as GPs,
hospitals and allied health practices.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jun 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jun 16
